Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia - Related Studies

Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia

This study has been completed.

Study NCT00004474. Last updated on October 1, 2008. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Aplastic Anemia

2	Additional conditions recognized in this trial
		Anemia
		Anemia, Aplastic

3	More general conditions related to this trial
		Bone Marrow Diseases
		Hematologic Diseases

4	Interventions listed in this trial
		Anti-thymocyte globulin
		Cyclophosphamide
		Bone marrow transplantation

5	Additional drug interventions recognized in this trial
		Antilymphocyte Serum

6	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antirheumatic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

7	Sponsors listed in this trial
		Roswell Park Cancer Institute